好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Determining the LVO Denominator: Estimating the Proportion of Large Vessel Ischemic Strokes When CTA is Unavailable
Cerebrovascular Disease and Interventional Neurology
P1 - Poster Session 1 (8:00 AM-9:00 AM)
5-012
To derive, test and externally validate LVO incidence measures using widely available data points, clinical findings, and imaging features on non-contrast head CT.

Precise determination of the region-specific prevalence of large vessel occlusion (LVO) acute ischemic stroke (AIS) is essential for system-wide planning and identifying access gaps for thrombectomy. Given the variability in LVO reporting (ranging from 13% to 52% of AIS) and absence of CT angiogram availability in most international regions, estimating true prevalence remains challenging. 

 
A retrospective chart review of all AIS patients from March to December 2021 at UT Health Houston was performed and data on demographics, initial CT ASPECTS, presence of cortical infarct on CT or MRI done at least 6 hours of presentation, NIHSS, and VAN score were collected. Gold standard was CTA-based definition of LVO, and the model was built using multivariable logistic regression and ROC analysis. Subsequently, the model was externally validated in a cohort of patients with AIS who received vascular imaging at the Medical City, Pasig, Philippines from January to October 2022.
Among 336 patients that met inclusion criteria at UTHealth, median age was 65, 48.9% were female and median NIHSS was 9. 54.8% patients had LVO confirmed on CTA. A multivariable regression using dichotomized NIHSS (>10), VAN (positive or negative) and presence of cortical changes on CT showed high classification performance (AUC 0.85) with sensitivity of 84% and specificity of 72%. Among the 200 patients that met criteria in the Philippines, a multivariable regression using the dichotomized NIHSS (>10), VAN (positive or negative) and presence of cortical changes on CT also showed high classification performance (AUC 0.79) with sensitivity of 64% and specificity of 86%.
Using widely available clinical data and non-contrast head CT features, LVO incidence can be accurately identified and may help under resourced settings identify accessibility gaps. 
Authors/Disclosures
Sushanth R. Aroor, MD
PRESENTER 		Dr. Aroor has stock in Gravity.
Ananya Iyyangar (UT Health Houston) Ananya Iyyangar has nothing to disclose.
Kimberly Geronimo No disclosure on file
Deepa Dongarwar (McGovern Medical School) Deepa Dongarwar has nothing to disclose.
Anjan Nagesh Ballekere (UT Health Science Center at Houston) No disclosure on file
Ngoc Mai Le (UT Health Houston) Ngoc Mai Le has nothing to disclose.
Hussain Azeem (UTHealth Houston) Hussain Azeem has nothing to disclose.
Rania Abdelkhaleq (UT Health) No disclosure on file
Amanda Jagolino-Cole, MD, FAAN (University of Texas Health Science Center At Houston) Dr. Jagolino-Cole has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生 - Neurology Clinical Practice Journal. .
Jo Ann Soliven No disclosure on file
Sunil Sheth, MD (University of Texas At Houston) Dr. Sheth has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Penumbra. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care.